quinacrine has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose-response measurements were used to generate multiparameter drug sensitivity scores using R-statistical language." | 1.46 | Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer. ( Af Hällström, TM; Aittokallio, T; Bychkov, D; Eldfors, S; Heckman, C; Horvath, P; Kallioniemi, O; Mirtti, T; Mpindi, JP; Östling, P; Paavolainen, L; Peehl, DM; Rahkama, V; Rannikko, A; Saeed, K; Wennerberg, K; Yadav, B, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saeed, K | 1 |
| Rahkama, V | 1 |
| Eldfors, S | 1 |
| Bychkov, D | 1 |
| Mpindi, JP | 1 |
| Yadav, B | 1 |
| Paavolainen, L | 1 |
| Aittokallio, T | 1 |
| Heckman, C | 1 |
| Wennerberg, K | 1 |
| Peehl, DM | 1 |
| Horvath, P | 1 |
| Mirtti, T | 1 |
| Rannikko, A | 1 |
| Kallioniemi, O | 1 |
| Östling, P | 1 |
| Af Hällström, TM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of Diagnostics and Treatment of Urological Cancers[NCT02994758] | 100 participants (Anticipated) | Interventional | 2017-11-27 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for quinacrine and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer.
Topics: Aniline Compounds; Antineoplastic Agents; Bexarotene; Cellular Reprogramming Techniques; Drug Screen | 2017 |